Full Text

Turn on search term navigation

© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Details

Title
Correction: Ferraz-Amaro et al. SCORE2 Assessment in The Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis. Diagnostics 2021, 11, 2363
Author
Ferraz-Amaro, Iván 1   VIAFID ORCID Logo  ; Corrales, Alfonso 2 ; Atienza-Mateo, Belén 2   VIAFID ORCID Logo  ; Vegas-Revenga, Nuria 3 ; Prieto-Peña, Diana 2 ; Sánchez-Martín, Julio 2 ; Almeida, Cristina 4 ; Quevedo-Abeledo, Juan Carlos 4 ; Blanco, Ricardo 2   VIAFID ORCID Logo  ; González-Gay, Miguel Á 5   VIAFID ORCID Logo 

 Division of Rheumatology, Hospital Universitario de Canarias, 38320 Tenerife, Spain; Internal Medicine Department, University of La Laguna, 38071 Tenerife, Spain 
 Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, 39008 Santander, Spain; [email protected] (A.C.); [email protected] (B.A.-M.); [email protected] (N.V.-R.); [email protected] (D.P.-P.); [email protected] (J.S.-M.); [email protected] (R.B.); Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, 39011 Santander, Spain 
 Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, 39008 Santander, Spain; [email protected] (A.C.); [email protected] (B.A.-M.); [email protected] (N.V.-R.); [email protected] (D.P.-P.); [email protected] (J.S.-M.); [email protected] (R.B.) 
 Division of Rheumatology, Hospital Doctor Negrín, 35010 Las Palmas de Gran Canaria, Spain; [email protected] (C.A.); [email protected] (J.C.Q.-A.) 
 Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, 39008 Santander, Spain; [email protected] (A.C.); [email protected] (B.A.-M.); [email protected] (N.V.-R.); [email protected] (D.P.-P.); [email protected] (J.S.-M.); [email protected] (R.B.); Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Hospital Universitario Marqués de Valdecilla, IDIVAL, 39011 Santander, Spain; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2000, South Africa 
First page
521
Publication year
2022
Publication date
2022
Publisher
MDPI AG
e-ISSN
20754418
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2632701416
Copyright
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.